Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter
- 18 November 2022
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 240 (1) , 1-13
Abstract
Rationale Assessment of the bioeffect of serotonin reuptake inhibitors (SRIs, including both selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs)) at the serotonin transporter (SERT) in patients and healthy controls can have important theoretical and clinical implications. Objectives Bioeffect at SERT has been assessed by neuroimaging of brain SERT occupancy, through in vitro measurements of platelet serotonin (5-HT) uptake, and by measuring platelet 5-HT content pre- and post-initiation of SRI administration. Studies of platelet 5-HT content were reviewed in order to (1) determine the overall apparent bioeffect of SRIs; (2) compare bioeffect across types of SRIs; (3) compare the three approaches to assessing SRI bioeffect; and (4) determine how the findings might inform clinical practice. Methods We performed a systematic review of the published studies that measured platelet 5-HT content to assess SRI bioeffect at the platelet SERT. Studies using neuroimaging and in vitro platelet 5-HT uptake to assess SRI bioeffect were reviewed for comparison purposes. Results Clinical doses of SRIs typically resulted in 70–90% reductions in platelet 5-HT content. The observed bioeffect at the platelet SERT appeared similar among different SSRIs and SNRIs. The bioeffect estimations based on platelet 5-HT content were consistent with those obtained using neuroimaging to assess brain SERT occupancy and those based on the in vitro measurement of platelet 5-HT uptake. Conclusions In general, excellent agreement was seen in the apparent SRI bioeffect (70–90% inhibition) among the platelet 5-HT content studies and across the three bioeffect approaches. Theoretical and practical clinical implications are discussed.Keywords
This publication has 107 references indexed in Scilit:
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant ActionArchives of General Psychiatry, 2006
- Early Effects of Paroxetine on Serotonin Storage, Plasma Levels, and Urinary ExcretionJournal of Clinical Psychopharmacology, 2004
- Peripheral Indices of Central Serotonin Function in HumansAnnals of the New York Academy of Sciences, 1990
- Steady-state model for plasma free and platelet serotonin in manLife Sciences, 1987
- Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrateLife Sciences, 1987
- Whole blood serotonin and plasma tryptophan using high-pressure liquid chromatography with electrochemical detectionBiochemical Medicine and Metabolic Biology, 1987
- Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients Biochemical aspectsActa Psychiatrica Scandinavica, 1986
- Platelet Serotonin Uptake Inhibition As a Basis for Monitoring Antidepressant Drug TreatmentJournal of Clinical Psychopharmacology, 1984
- Chronic treatment with clomipramine or maprotiline depletes platelet serotonin and modifies its diurnal rhythmProgress in Neuro-Psychopharmacology, 1978
- Decreased blood level of 5-hydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptakeLife Sciences, 1976